GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 14, 2024 |
PDB ID | UniProt ID | Title | Descriptor ▲ |
---|---|---|---|
7P5M | Q9BSA4 | Cryo-EM structure of human TTYH2 in lipid nanodiscs | |
7P77 | 7P77 | SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 3up conformation | |
7P77 | P0DTC2 | SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 3up conformation | |
7P78 | P0DTC2 | SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 1up/1up-out/1down conformation | |
7P78 | 7P78 | SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 1up/1up-out/1down conformation | |
7P79 | P0DTC2 | SARS-CoV-2 spike protein in complex with sybodyb#15 in a 1up/1up-out/1down conformation. | |
7P79 | 7P79 | SARS-CoV-2 spike protein in complex with sybodyb#15 in a 1up/1up-out/1down conformation. | |
7P7A | 7P7A | SARS-CoV-2 spike protein in complex with sybody#68 in a 2up/1flexible conformation | |
7P7A | P0DTC2 | SARS-CoV-2 spike protein in complex with sybody#68 in a 2up/1flexible conformation | |
7R6W | 7R6W | SARS-CoV-2 spike receptor-binding domain (RBD) in complex with S2X35 Fab and S309 Fab | |
7R6W | P0DTC2 | SARS-CoV-2 spike receptor-binding domain (RBD) in complex with S2X35 Fab and S309 Fab | |
7R6X | 7R6X | SARS-CoV-2 spike receptor-binding domain (RBD) in complex with S2E12 Fab, S309 Fab, and S304 Fab | |
7R6X | P0DTC2 | SARS-CoV-2 spike receptor-binding domain (RBD) in complex with S2E12 Fab, S309 Fab, and S304 Fab | |
7R7N | P0DTC2 | SARS-CoV-2 spike in complex with the S2D106 neutralizing antibody Fab fragment (local refinement of the RBD and S2D106) | |
7R7N | 7R7N | SARS-CoV-2 spike in complex with the S2D106 neutralizing antibody Fab fragment (local refinement of the RBD and S2D106) | |
7R8L | 7R8L | Structure of the SARS-CoV-2 RBD in complex with neutralizing antibody C099 and CR3022 | |
7R8L | P0DTC2 | Structure of the SARS-CoV-2 RBD in complex with neutralizing antibody C099 and CR3022 | |
7R8M | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C032 | |
7R8M | 7R8M | Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C032 | |
7R8N | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C051 | |
7R8N | 7R8N | Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C051 | |
7R8O | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C548 | |
7R8O | 7R8O | Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C548 | |
7RA8 | P0DTC2 | SARS-CoV-2 S glycoprotein in complex with S2X259 Fab | |
7RA8 | 7RA8 | SARS-CoV-2 S glycoprotein in complex with S2X259 Fab | |
7RAL | P0DTC2 | SARS-CoV-2 S bound to S2X259 Fab (local refinement of the RBD/S2X259 variable domains) | |
7RAL | 7RAL | SARS-CoV-2 S bound to S2X259 Fab (local refinement of the RBD/S2X259 variable domains) | |
7RNN | 7RNN | Human ASIC1a-Nb.C1 complex | |
7RNN | P78348 | Human ASIC1a-Nb.C1 complex | |
7RSN | 7RSN | AMC018 SOSIP.v4.2 in complex with PGV04 Fab | |
7RSO | 7RSO | AMC016 SOSIP.v4.2 in complex with PGV04 Fab | |
7RTT | Q3TH73 | Cryo-EM structure of a TTYH2 cis-dimer | |
7RTU | Q3TH73 | Cryo-EM structure of a TTYH2 trans-dimer | |
7RTW | Q6P5F7 | Cryo-EM structure of a TTYH3 cis-dimer | |
7RW2 | P0DTC2 | Cryo-EM structure of NTD-directed neutralizing antibody 5-7 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
7RW2 | 7RW2 | Cryo-EM structure of NTD-directed neutralizing antibody 5-7 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
7RY8 | A6ZSR0 | S. CEREVISIAE CYP51 Y140H mutant COMPLEXED WITH Voriconazole | |
7S0Z | M4NKV9 | Structures of TcdB in complex with R-Ras | |
7S0Z | P10301 | Structures of TcdB in complex with R-Ras | |
8A3H | P06565 | Cellobiose-derived imidazole complex of the endoglucanase cel5A from Bacillus agaradhaerens at 0.97 A resolution | |
8ABP | P02924 | SUGAR-BINDING AND CRYSTALLOGRAPHIC STUDIES OF AN ARABINOSE-BINDING PROTEIN MUTANT (MET108LEU) WHICH EXHIBITS ENHANCED AFFINITY AND ALTERED SPECIFICITY | |
8API | P01009 | THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN, STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM | |
8AT1 | P0A786 | CRYSTAL STRUCTURES OF ASPARTATE CARBAMOYLTRANSFERASE LIGATED WITH PHOSPHONOACETAMIDE, MALONATE, AND CTP OR ATP AT 2.8-ANGSTROMS RESOLUTION AND NEUTRAL P*H | |
8AT1 | P0A7F3 | CRYSTAL STRUCTURES OF ASPARTATE CARBAMOYLTRANSFERASE LIGATED WITH PHOSPHONOACETAMIDE, MALONATE, AND CTP OR ATP AT 2.8-ANGSTROMS RESOLUTION AND NEUTRAL P*H | |
8CGT | P30920 | STRUCTURE OF CYCLODEXTRIN GLYCOSYLTRANSFERASE COMPLEXED WITH A THIO-MALTOHEXAOSE | |
8PCH | O46427 | CRYSTAL STRUCTURE OF PORCINE CATHEPSIN H DETERMINED AT 2.1 ANGSTROM RESOLUTION: LOCATION OF THE MINI-CHAIN C-TERMINAL CARBOXYL GROUP DEFINES CATHEPSIN H AMINOPEPTIDASE FUNCTION | |
8PCH | 8PCH | CRYSTAL STRUCTURE OF PORCINE CATHEPSIN H DETERMINED AT 2.1 ANGSTROM RESOLUTION: LOCATION OF THE MINI-CHAIN C-TERMINAL CARBOXYL GROUP DEFINES CATHEPSIN H AMINOPEPTIDASE FUNCTION | |
8RUC | P00875 | ACTIVATED SPINACH RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL BISPHOSPHATE | |
8RUC | P00870 | ACTIVATED SPINACH RUBISCO COMPLEXED WITH 2-CARBOXYARABINITOL BISPHOSPHATE | |
8XIA | P24300 | X-RAY ANALYSIS OF D-XYLOSE ISOMERASE AT 1.9 ANGSTROMS: NATIVE ENZYME IN COMPLEX WITH SUBSTRATE AND WITH A MECHANISM-DESIGNED INACTIVATOR |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024